mRNA-based COVID-19 vaccines are effective against Indian SARS-CoV-2 variant, says study

By | May 12, 2021
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).